170 related articles for article (PubMed ID: 24851136)
1. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study.
Nouri K; Haslinger P; Szabo L; Sator M; Schreiber M; Schneeberger C; Pietrowski D
J Ovarian Res; 2014; 7():54. PubMed ID: 24851136
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype.
Hanevik HI; Hilmarsen HT; Skjelbred CF; Tanbo T; Kahn JA
Gynecol Endocrinol; 2012 Nov; 28(11):845-9. PubMed ID: 22587628
[TBL] [Abstract][Full Text] [Related]
3. Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome.
O'Brien TJ; Harralson AF; Tran T; Gindoff I; Orkunoglu-Suer FE; Frankfurter D; Gindoff P
Reprod Biol Endocrinol; 2014 May; 12():36. PubMed ID: 24886133
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
Pietrowski D; Szabo L; Sator M; Just A; Egarter C
Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
[TBL] [Abstract][Full Text] [Related]
6. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
10. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.
Marks ECA; Wilkinson TM; Frampton CM; Skelton L; Pilbrow AP; Yandle TG; Pemberton CJ; Doughty RN; Whalley GA; Ellis CJ; Troughton RW; Owen MC; Pattinson NR; Cameron VA; Richards AM; Gieseg SP; Palmer BR
BMC Cardiovasc Disord; 2018 Aug; 18(1):169. PubMed ID: 30111293
[TBL] [Abstract][Full Text] [Related]
12. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
[TBL] [Abstract][Full Text] [Related]
13. The implication of single-nucleotide polymorphisms in ovarian hyperstimulation syndrome.
Ghaderian SMH; Akbarzadeh R; Mohajerani F; Khodaii Z; Salehpour S
Mol Reprod Dev; 2019 Aug; 86(8):964-971. PubMed ID: 31115963
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.
Kim DH; Xu W; Kamel-Reid S; Liu X; Jung CW; Kim S; Lipton JH
Ann Oncol; 2010 Jun; 21(6):1179-1188. PubMed ID: 19875757
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
16. Melatonin stimulates VEGF expression in human granulosa-lutein cells: A potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
Li Y; Fang L; Zhang R; Wang S; Li Y; Yan Y; Yu Y; Cheng JC; Sun YP
Mol Cell Endocrinol; 2020 Dec; 518():110981. PubMed ID: 32791190
[TBL] [Abstract][Full Text] [Related]
17. Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2015 Jun; 36(6):4223-34. PubMed ID: 25604142
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome].
Kalitin NN; Dudina GA; Semochkin SV; Karamysheva AF
Ter Arkh; 2017; 89(7):39-44. PubMed ID: 28766539
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
